The consultation period for the draft proposed Rules of Procedure of the Unified Patents Court (“Rules”) closes on 1 October 2013. Any life science business with European operations will, sooner or later, find itself before the Unified Patents Court once it becomes operational, either as a claimant or defendant. The consequences of that litigation will be significant because the decision will affect the whole of Europe, rather than being confined to a single country as under the current litigation model. The impact of the Rules will therefore be far-reaching, particularly for the life sciences industry, relying as it does on a relatively small number of patents to protect its key products. Now is your last chance to influence the system!
As explained here, in December 2012 the European Parliament voted in favour of the Unitary EU Patent. The European Commission anticipated that the first Unitary EU Patent would be granted in 2014, although this time line now appears to be delayed.
Continue Reading Time Is Running Out for Commenting on the Unified Patent Court Rules